PHÂN TÍCH XU HƯỚNG SỬ DỤNG THUỐC BẢO HIỂM Y TẾ TẠI BỆNH VIỆN ĐA KHOA TỈNH LÂM ĐỒNG GIAI ĐOẠN 2018-2023

Abstract

Objective: This study aims to provide an overview analysis of the utilization trends of drugs covered by health insurance (HI) at Lam Dong General Hospital (LDGH) during the period from 2018 to 2023. Materials and Methods: This cross-sectional descriptive study was conducted by retrospectively reviewing the entire dataset of Western medicines, traditional medicines, radiopharmaceuticals, blood, and blood products. The trends in drug utilization were evaluated based on changes in the characteristics of the drug list, cost values, and the structural changes in drug expenditure over the years from 2018 to 2023. Data were aggregated, analyzed, and illustrated using Microsoft Excel. Results: The drug list during the period from 2018 to 2023 fluctuated between 634 to 700 products, with Western medicines consistently accounting for over 86% of the list. From 2018 to 2023, the total expenditure for HI-covered drugs used by patients at LDGH was VND 684 billion, with outpatient drugs comprising 57,7%. During this period, outpatient drug costs decreased, inpatient drug costs increased, traditional medicine costs decreased, radiopharmaceutical costs increased, and the costs for blood and blood products increased. Conclusion: These results provide LDGH management with a comprehensive overview of the drug supply and utilization situation at the hospital, aiding in more rational and effective decision-making processes